Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 12/17/2027 | PUT | $100.00 | 30 | +30 | |
| 06/18/2026 | PUT | $95.00 | 36 | +17 | +89.47% |
| 10/16/2026 | CALL | $110.00 | 7 | +4 | +133.33% |
| 10/16/2026 | PUT | $105.00 | 6 | +4 | +200.00% |
| 01/15/2027 | CALL | $150.00 | 4 | +3 | +300.00% |
| 06/18/2026 | CALL | $100.00 | 804 | +1 | +0.12% |
| 12/17/2027 | PUT | $155.00 | 0 | 0 | |
| 12/17/2027 | PUT | $160.00 | 0 | 0 | |
| 06/18/2026 | CALL | $130.00 | 13 | -1 | -7.14% |
| 06/18/2026 | PUT | $150.00 | 0 | -1 | -100.00% |
| 06/18/2026 | PUT | $155.00 | 0 | -1 | -100.00% |
| 01/15/2027 | PUT | $90.00 | 100 | -1 | -0.99% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Mutual Fund Ser Tr-Eventide Healthcare & Life Sciences Fund | 5.42% | 2.06M | 54.1M |
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 3.27% | 1.24M | 32.61M |
| Vanguard Total Stock Market Index Fund | 2.05% | 777.29k | 20.44M |
| iShares Russell 2000 ETF | 1.08% | 408k | 10.73M |
| Vanguard Extended Market Index Fund | 0.89% | 336.41k | 8.85M |
| iShares NASDAQ Biotechnology ETF | 0.48% | 181.62k | 4.78M |
| Fidelity Small Cap Index Fund | 0.40% | 153.12k | 4.03M |
| iShares Russell 2000 Growth ETF | 0.38% | 143.27k | 3.77M |
| Franklin Strategic Series-Franklin Biotechnology Discove | 0.34% | 130.6k | 3.43M |
| Fidelity Extended Market Index Fund | 0.33% | 126.79k | 3.33M |
Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026
03/20 12:07 pm
The Motley Fool
Read moreXOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements
03/18 06:00 am
GlobeNewswire Inc.
Read moreIs Mirum Pharmaceuticals on a Strong Path to Profitability?
01/31 04:02 pm
The Motley Fool
Read morePrediction: This Stock Has Soared Nearly 70% in 2025 and Will Be an Even Bigger Winner in 2026
12/03 07:30 am
The Motley Fool
Read moreMirum (MIRM) Soars on Interim Data From Liver Disease Studies
06/18 11:14 am
Zacks Investment Research
Read moreMirum Pharmaceuticals (MIRM) Soars 27.3%: Is Further Upside Left in the Stock?
06/18 05:46 am
Zacks Investment Research
Read moreWhy Is Mirum Pharmaceuticals (MIRM) Down 3.4% Since Last Earnings Report?
06/07 11:30 am
Zacks Investment Research
Read moreMirum's (MIRM) Livmarli Aids Sales but Overdependence Concerns
05/28 10:02 am
Zacks Investment Research
Read moreMirum's (MIRM) Q1 Earnings & Revenues Fall Shy of Estimates
05/09 11:46 am
Zacks Investment Research
Read moreAnalyst Ratings For Mirum Pharmaceuticals
05/09 08:01 am
Benzinga
Read moreHalozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?
04/30 10:01 am
Zacks Investment Research
Read moreMirum Pharmaceuticals, Inc. (MIRM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
04/25 10:02 am
Zacks Investment Research
Read moreSome Bubbles Are Starting To Pop
04/21 10:49 am
Seeking Alpha
Read moreAnalyst Ratings For Mirum Pharmaceuticals
04/17 09:00 am
Benzinga
Read moreMirum Pharmaceuticals (MIRM) Down 12.5% Since Last Earnings Report: Can It Rebound?
03/29 11:30 am
Zacks Investment Research
Read more$5M Bet On Snowflake? Check Out These 4 Stocks Insiders Are Buying
03/28 08:33 am
Benzinga
Read moreCracking The Code: Understanding Analyst Reviews For Mirum Pharmaceuticals
03/18 03:00 pm
Benzinga
Read moreMirum's (MIRM) Livmarli Receives FDA Nod for Expanded Use
03/15 09:32 am
Zacks Investment Research
Read moreFDA Approves Mirum's Livmarli For Liver Disease In Kids As Young As 5 Years: Analyst Bullish On Label Expansion Strategy
03/14 03:40 pm
Benzinga
Read moreCritical Insights From Mirum Pharmaceuticals Analyst Ratings: What You Need To Know
02/29 03:02 pm
Benzinga
Read moreMirum's (MIRM) Q4 Earnings Lag Estimates, Revenues Beat
02/29 12:34 pm
Zacks Investment Research
Read moreMirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates
02/28 06:35 pm
Zacks Investment Research
Read moreSarepta Therapeutics (SRPT) Moves 7.8% Higher: Will This Strength Last?
02/19 04:26 am
Zacks Investment Research
Read moreWhere Mirum Pharmaceuticals Stands With Analysts
01/11 02:00 pm
Benzinga
Read moreVeradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesday
01/10 11:27 am
Benzinga
Read moreThe Latest Analyst Ratings For Mirum Pharmaceuticals
12/19 02:00 pm
Benzinga
Read moreMirum (MIRM) Down on Failure of Mid-Stage Study on Livmarli
12/19 12:44 pm
Zacks Investment Research
Read moreUber To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Tuesday
12/19 08:30 am
Benzinga
Read more11 Analysts Have This to Say About Mirum Pharmaceuticals
11/20 11:00 am
Benzinga
Read moreAnalyst Ratings for Mirum Pharmaceuticals
11/03 11:00 am
Benzinga
Read moreApellis Pharmaceuticals, Inc. (APLS) Reports Q3 Loss, Tops Revenue Estimates
11/01 08:25 am
Zacks Investment Research
Read moreNeoGenomics (NEO) Expected to Beat Earnings Estimates: Should You Buy?
10/30 10:00 am
Zacks Investment Research
Read moreBenzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
10/24 11:00 am
Benzinga
Read moreAnalyst Ratings for Mirum Pharmaceuticals
10/09 02:00 pm
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For September 20, 2023
09/20 11:00 am
Benzinga
Read moreStrength Seen in Mirum Pharmaceuticals, Inc. (MIRM): Can Its 8.0% Jump Turn into More Strength?
09/15 06:01 am
Zacks Investment Research
Read moreAnalyst Ratings for Mirum Pharmaceuticals
09/13 08:01 am
Benzinga
Read moreMirum Pharma (MIRM) Stock Rises 42% Year to Date: Here's Why
09/06 11:19 am
Zacks Investment Research
Read moreAround $4M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
09/06 06:48 am
Benzinga
Read moreWhere Mirum Pharmaceuticals Stands With Analysts
08/21 11:00 am
Benzinga
Read moreMirum Pharmaceuticals, Inc. (MIRM) Reports Q2 Loss, Tops Revenue Estimates
08/03 05:25 pm
Zacks Investment Research
Read moreRaymond James Maintains Strong Buy Rating for Mirum Pharmaceuticals: Here's What You Need To Know
07/18 01:00 pm
Benzinga
Read moreMicrosoft To Rally Around 16%? Here Are 10 Other Analyst Forecasts For Tuesday
07/18 07:37 am
Benzinga
Read moreAnalyst Expectations for Mirum Pharmaceuticals's Future
05/22 10:02 am
Benzinga
Read moreMirum Pharmaceuticals, Inc. (MIRM) Reports Q1 Loss, Tops Revenue Estimates
05/04 06:05 pm
Zacks Investment Research
Read moreAdaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates
05/03 05:25 pm
Zacks Investment Research
Read moreVBI Vaccines, Inc. (VBIV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
05/01 10:00 am
Zacks Investment Research
Read more